Novel IDH1-Targeting Fluorescent Probe Enables Intraoperative Visualization and Resection of Glioblastoma

Key Points

• Evaluate the effectiveness of a novel IDH1-targeting fluorescent probe for visualizing glioblastoma during surgery.
• Conducted a randomized trial comparing fluorescence-guided surgery to standard procedures.
• Utilized an IDH1-targeting fluorescent probe for real-time intraoperative visualization.
• Analyzed surgical outcomes and resection rates based on probe administration.
• Significantly improved visualization of glioblastoma with IDH1-targeting probe compared to standard methods.
• Higher resection rates observed with the fluorescent probe approach (exact rates not provided).
• Enhanced understanding of IDH1-associated pathophysiology during surgery.